Skip to main content
Retour
Watch Compare

Ovid Therapeutics Inc.

Qualité des données : 100%
OVID
Nasdaq Manufacturing Chemicals
2,85 €
▲ 0,25 € (9,62%)
Cap. Boursière: 430,43 M
Prix
2,85 €
Cap. Boursière
430,43 M
Fourchette du Jour
2,65 € — 3,11 €
Fourchette 52 Semaines
0,25 € — 3,11 €
Volume
5 294 357
Ouverture 2,68 €
Moyenne 50J / 200J
1,85 €
54,25% above
Moyenne 50J / 200J
1,36 €
109,36% above

Quick Summary

Points Clés

Negative free cash flow of -38,33 M
Capital efficient — spends only 0,00% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)1181,27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-34,66%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-53,41%
Net Margin-240,13%
Op. Margin-585,20%

Sécurité

Debt / Equity
N/A
Current Ratio4,24
Interest CoverageN/A

Valorisation

PE (TTM)
-24,72
En dessous de la moyenne du secteur (-1,47)
P/B Ratio9,63
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -24,7 -1,5
P/B 9,6 1,6
ROE % -34,7 -53,5
Net Margin % -240,1 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 1181,27% Revenue Growth (3Y) -81,96%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7,25 M Net Income (TTM) -17,41 M
ROE -34,66% ROA -24,65%
Gross Margin N/A Operating Margin -585,20%
Net Margin -240,13% Free Cash Flow (TTM) -38,33 M
ROIC -53,41% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,24
Interest Coverage N/A Asset Turnover 0,10
Working Capital 22,03 M Tangible Book Value 44,70 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -24,72 Forward P/E N/A
P/B Ratio 9,63 P/S Ratio 59,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,91%
Market Cap 430,43 M Enterprise Value 409,82 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,05
FCF / Share -0,25 OCF / Share -0,25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 220,13%
SBC-Adj. FCF -43,25 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 7,25 M 566 000,0 222,80 M 222,50 M —
Net Income -17,41 M -26,43 M -52,34 M -54,17 M 122,83 M
EPS (Diluted) — — -0,74 -0,77 1,76
Gross Profit — — — — —
Operating Income -42,44 M -61,89 M -59,28 M -55,55 M 124,21 M
EBITDA — — — — —
R&D Expenses 25,58 M 36,77 M 28,59 M 24,62 M 46,94 M
SG&A Expenses — — — — —
D&A 273 000,0 613 000,0 568 282,0 512 505,0 237 079,0
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 1,33 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 150,93 M 92,17 M 144,03 M 155,27 M 194,54 M
Total Liabilities 20,27 M 23,94 M 56,23 M 22,99 M 14,80 M
Shareholders' Equity 130,66 M 68,23 M 87,80 M 132,27 M 179,75 M
Total Debt — — — — —
Cash & Equivalents 13,15 M 26,30 M 27,04 M 44,87 M 187,80 M
Current Assets 74,37 M 55,94 M 109,60 M 131,38 M 190,48 M
Current Liabilities 8,29 M 10,52 M 11,47 M 6,99 M 14,80 M